Thomas Andrew Crockett Insider Profile

11 Followers
Thomas Andrew Crockett, CEO, Director at KalVista Pharmaceuticals, holds 211.20K shares in KalVista Pharmaceuticals (Ticker: KALV).
tipranks
Thomas Andrew Crockett

Thomas Andrew Crockett
KalVista Pharmaceuticals (KALV)
CEO, Director

Not Ranked
Thomas Andrew Crockett has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
A breakdown of Thomas Andrew Crockett's holdings

Insider Roles

KalVista Pharmaceuticals
(KALV)
CEO, Director
Roles that Thomas Andrew Crockett holds in companies

Most Profitable Insider Trade

Stock:
KalVista Pharmaceuticals
(KALV)
Rating:Informative Sell
Date:Feb 16, 2024 - Today
Return:+28.60%
The most profitable trade made by Thomas Andrew Crockett

Thomas Andrew Crockett's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
KalVista Pharmaceuticals
Feb 21, 2024
CEO, Director
Uninformative Buy
438.77K
$2.38M
Success Rate for
KALV
1 out of 1 profitable transactions on
KALV
100%
Average Return for
KALV
Average return per transaction on
KALV
+28.60%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Feb 13, 2024
Uninformative Buy
$0.00
-
$0.00
Aug 19, 2022
Uninformative Buy
$59.96K
-
$14.96
Nov 21, 2022
Uninformative Buy
$21.59K
-
$5.38
Nov 21, 2023
Uninformative Buy
$152.46K
-
$8.15
Feb 21, 2024
Uninformative Buy
$438.77K
-
$14.62
List of latest transactions for each holding click on a transaction to see Thomas Andrew Crockett's performance on stock

Thomas Andrew Crockett insider profile FAQ

What is the percentage of profitable transactions made by Thomas Andrew Crockett?
The percentage of profitable transactions made by Thomas Andrew Crockett is ―.
    What is the average return per transaction made by Thomas Andrew Crockett?
    The average return per transaction made by Thomas Andrew Crockett is ―.
      What stocks does Thomas Andrew Crockett hold?
      Thomas Andrew Crockett holds: KALV stocks.
        What was Thomas Andrew Crockett’s latest transaction?
        Thomas Andrew Crockett latest transaction was an Uninformative Buy of $438.77K.
          What was Thomas Andrew Crockett's most profitable transaction?
          Thomas Andrew Crockett’s most profitable transaction was an Informative Sell of KALV stock on February 16, 2024. The return on the trade was 28.60%.
            What is Thomas Andrew Crockett's role in KalVista Pharmaceuticals?
            Thomas Andrew Crockett's role in KalVista Pharmaceuticals is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.